RCUS
$22.12-3.07%
Arcus Biosciences Inc. monthly returns
Arcus Biosciences Inc. has averaged 2.69% per month, positive in 48% of months. Month-by-month returns for Arcus Biosciences Inc. (RCUS) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Average month
+2.7%
94 months
Best month
+90.3%
Apr 2020
Worst month
-41.2%
Dec 2022
Positive months
48%
of all months
Arcus Biosciences Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -14.4% | |
| Sep 2026 | -11.8% | |
| Aug 2026 | +3.9% | |
| Jul 2026 | -8.6% | |
| Jun 2026 | +21.7% | |
| May 2026 | -0.6% | |
| Apr 2026 | +18.1% | |
| Mar 2026 | +6.0% | |
| Feb 2026 | -3.2% | |
| Jan 2026 | -11.7% | |
| Dec 2025 | -8.7% | |
| Nov 2025 | +32.4% | |
| Oct 2025 | +45.0% | |
| Sep 2025 | +28.4% | |
| Aug 2025 | +16.0% | |
| Jul 2025 | +12.2% | |
| Jun 2025 | -8.8% | |
| May 2025 | +2.1% | |
| Apr 2025 | +11.5% | |
| Mar 2025 | -27.9% | |
| Feb 2025 | -15.6% | |
| Jan 2025 | -13.4% | |
| Dec 2024 | -3.6% | |
| Nov 2024 | +0.9% | |
| Oct 2024 | +0.1% | |
| Sep 2024 | -10.7% | |
| Aug 2024 | +4.3% | |
| Jul 2024 | +7.7% | |
| Jun 2024 | +1.1% | |
| May 2024 | -1.1% | |
| Apr 2024 | -19.3% | |
| Mar 2024 | -1.3% | |
| Feb 2024 | +26.4% | |
| Jan 2024 | -20.7% | |
| Dec 2023 | +26.8% | |
| Nov 2023 | -4.1% | |
| Oct 2023 | -12.5% | |
| Sep 2023 | -12.4% | |
| Aug 2023 | +3.0% | |
| Jul 2023 | -2.0% | |
| Jun 2023 | -1.1% | |
| May 2023 | +15.1% | |
| Apr 2023 | -2.1% | |
| Mar 2023 | +0.2% | |
| Feb 2023 | -15.8% | |
| Jan 2023 | +4.6% | |
| Dec 2022 | -41.2% | |
| Nov 2022 | +38.0% | |
| Oct 2022 | -2.6% | |
| Sep 2022 | +8.6% | |
| Aug 2022 | -9.4% | |
| Jul 2022 | +4.9% | |
| Jun 2022 | +33.7% | |
| May 2022 | -21.7% | |
| Apr 2022 | -23.3% | |
| Mar 2022 | -15.2% | |
| Feb 2022 | +20.8% | |
| Jan 2022 | -23.9% | |
| Dec 2021 | -7.6% | |
| Nov 2021 | +31.0% | |
| Oct 2021 | -4.1% | |
| Sep 2021 | +19.5% | |
| Aug 2021 | -7.1% | |
| Jul 2021 | +14.4% | |
| Jun 2021 | +10.6% | |
| May 2021 | -26.5% | |
| Apr 2021 | +20.2% | |
| Mar 2021 | -20.4% | |
| Feb 2021 | +1.5% | |
| Jan 2021 | +33.8% | |
| Dec 2020 | -4.7% | |
| Nov 2020 | +24.9% | |
| Oct 2020 | +27.2% | |
| Sep 2020 | -28.0% | |
| Aug 2020 | +20.9% | |
| Jul 2020 | -20.5% | |
| Jun 2020 | -21.1% | |
| May 2020 | +18.7% | |
| Apr 2020 | +90.3% | |
| Mar 2020 | -8.8% | |
| Feb 2020 | +73.3% | |
| Jan 2020 | -13.1% | |
| Dec 2019 | +22.1% | |
| Nov 2019 | +5.4% | |
| Oct 2019 | -13.7% | |
| Sep 2019 | +16.5% | |
| Aug 2019 | -1.3% | |
| Jul 2019 | -0.5% | |
| Jun 2019 | -6.3% | |
| May 2019 | -12.8% | |
| Apr 2019 | -22.2% | |
| Mar 2019 | +5.9% | |
| Feb 2019 | +15.9% | |
| Jan 2019 | -5.6% | |
| Dec 2018 | -5.7% | |
| Nov 2018 | +13.6% | |
| Oct 2018 | -27.9% | |
| Sep 2018 | -3.2% | |
| Aug 2018 | +23.1% | |
| Jul 2018 | -4.4% | |
| Jun 2018 | -23.2% | |
| May 2018 | +4.7% | |
| Apr 2018 | -1.4% |
Monthly total return (since Nov 2021)#
-40%-20%0%20%40%
Nov 2021+31%
Dec 2021-7.6%
Jan 2022-24%2022
Feb 2022+21%
Mar 2022-15%
Apr 2022-23%
May 2022-22%
Jun 2022+34%
Jul 2022+4.9%
Aug 2022-9.4%
Sep 2022+8.6%
Oct 2022-2.6%
Nov 2022+38%
Dec 2022-41%
Jan 2023+4.6%2023
Feb 2023-16%
Mar 2023+0.16%
Apr 2023-2.1%
May 2023+15%
Jun 2023-1.1%
Jul 2023-2.0%
Aug 2023+3.0%
Sep 2023-12%
Oct 2023-12%
Nov 2023-4.1%
Dec 2023+27%
Jan 2024-21%2024
Feb 2024+26%
Mar 2024-1.3%
Apr 2024-19%
May 2024-1.1%
Jun 2024+1.1%
Jul 2024+7.7%
Aug 2024+4.3%
Sep 2024-11%
Oct 2024+0.07%
Nov 2024+0.92%
Dec 2024-3.6%
Jan 2025-13%2025
Feb 2025-16%
Mar 2025-28%
Apr 2025+11%
May 2025+2.1%
Jun 2025-8.8%
Jul 2025+12%
Aug 2025+16%
Sep 2025+28%
Oct 2025+45%
Nov 2025+32%
Dec 2025-8.7%
Jan 2026-12%2026
Feb 2026-3.2%
Mar 2026+6.0%
Apr 2026+18%
May 2026-0.63%
Jun 2026+22%
Jul 2026-8.6%
Aug 2026+3.9%
Sep 2026-12%
Oct 2026-14%
Arcus Biosciences Inc. returns by calendar month#
Every month of every year since 2019, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -14.36% — 8th of 8 Octobers since 2019 at the last close; the average October returned +5.6%.
| Month | −95%0+95% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | -6.2% | -12.4% | 25% | +33.8% 2021 | -23.9% 2022 | |
| Feb | +12.9% | +8.7% | 63% | +73.3% 2020 | -15.8% 2023 | |
| Mar | -7.7% | -5.1% | 38% | +6.0% 2026 | -27.9% 2025 | |
| Apr | +9.1% | +4.7% | 50% | +90.3% 2020 | -23.3% 2022 | |
| May | -3.3% | -0.8% | 38% | +18.7% 2020 | -26.5% 2021 | |
| Jun | +3.7% | -0.0% | 50% | +33.7% 2022 | -21.1% 2020 | |
| Jul | +1.0% | +2.2% | 50% | +14.4% 2021 | -20.5% 2020 | |
| Aug | +3.8% | +3.4% | 63% | +20.9% 2020 | -9.4% 2022 | |
| Sep | +1.3% | -1.0% | 50% | +28.4% 2025 | -28.0% 2020 | |
| Oct | +5.6% | -2.6% | 43% | +45.0% 2025 | -13.7% 2019 | |
| Nov | +18.3% | +24.9% | 86% | +38.0% 2022 | -4.1% 2023 | |
| Dec | -2.4% | -4.7% | 29% | +26.8% 2023 | -41.2% 2022 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from RCUS's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Arcus Biosciences Inc.'s average monthly return?
- Arcus Biosciences Inc. (RCUS) has averaged about 2.69% per month, positive in roughly 48% of months. The best month was Apr 2020 (+90.3%) and the worst was Dec 2022 (-41.2%).
More on Arcus Biosciences Inc.
By month for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100